Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Sotera Health Co's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $444 Mil. Sotera Health Co's Total Assets for the quarter that ended in Dec. 2023 was $3,130 Mil.
Therefore, Sotera Health Co's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.14.
The historical rank and industry rank for Sotera Health Co's Equity-to-Asset or its related term are showing as below:
SHC'
s Equity-to-Asset Range Over the Past 10 Years
Min: -0.25 Med: 0.13 Max: 0.21
Current: 0.14
During the past 6 years, the highest Equity to Asset Ratio of Sotera Health Co was 0.21. The lowest was -0.25. And the median was 0.13.
SHC's Equity-to-Asset is ranked worse than 85.71% of 238
companies
in the Medical Diagnostics & Research industry
Industry Median: 0.58
vs SHC: 0.14
Sotera Health Co Equity-to-Asset Historical Data
The historical data trend for Sotera Health Co's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Sotera Health Co's Equity-to-Asset
For the Diagnostics & Research subindustry, Sotera Health Co's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sotera Health Co's Equity-to-Asset Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Sotera Health Co's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Sotera Health Co's Equity-to-Asset falls into.
Sotera Health Co Equity-to-Asset Calculation
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Sotera Health Co's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sotera Health Co (NAS:SHC) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Sotera Health Co Equity-to-Asset Related Terms
Thank you for viewing the detailed overview of Sotera Health Co's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.
Sotera Health Co (Sotera Health Co) Business Description
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three segments: Sterigenics, Nordion, and Nelson Labs. Sterigenics provides outsourced terminal sterilization and irradiation services for medical device, pharmaceutical, food safety, and advanced applications; Nordion provides Co-60 and gamma irradiators, which are the key components to the gamma sterilization process; and Nelson Labs provides outsourced microbiological and analytical chemistry testing for the medical device and pharmaceutical industries. Its geographical segments are the United States, Canada, Europe, and other regions.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SHC has been successfully added to your 